RNA aptamers targeting cancer stem cell marker CD133

被引:137
作者
Shigdar, Sarah [1 ]
Qiao, Liang [2 ,3 ]
Zhou, Shu-Feng [4 ]
Xiang, Dongxi [1 ]
Wang, Tao [1 ,5 ]
Li, Yong [6 ,7 ]
Lim, Lee Yong [8 ]
Kong, Lingxue [9 ]
Li, Lianhong [10 ]
Duan, Wei [1 ,10 ]
机构
[1] Deakin Univ, Sch Med, Waurn Ponds, Vic 3217, Australia
[2] Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Dept Med, Westmead, NSW 2145, Australia
[3] Univ Sydney, Western Clin Sch, Westmead, NSW 2145, Australia
[4] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33612 USA
[5] Zhengzhou Univ, Coll Nursing, Zhengzhou 450052, Peoples R China
[6] Univ New S Wales, Canc Care Ctr, St George Hosp, Kensington, NSW 2052, Australia
[7] Univ New S Wales, St George Clin Sch, Fac Med, Kensington, NSW 2052, Australia
[8] Univ Western Australia, Lab Drug Delivery, Crawley, WA 6009, Australia
[9] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic 3217, Australia
[10] Dalian Med Univ, Dept Pathol & Forens Sci, Dalian 116044, Peoples R China
关键词
AC133; Cancer stem cell; CD133; RNA aptamer; SELEX; Therapeutic; CD133(+)CD44(+) POPULATION; IDENTIFICATION; EXPRESSION; AC133; THERAPY; PROTEIN; DIFFERENTIATION; IMMUNOTHERAPY; RECOGNITION; PROMININ-1;
D O I
10.1016/j.canlet.2012.11.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The monoclonal antibody against the AC133 epitope of CD133 has been widely used as a cell surface marker of cancer stem cells in several different cancer types. Here, we describe the isolation and characterisation of two RNA aptamers, including the smallest described 15 nucleotide RNA aptamer, which specifically recognise the AC133 epitope and the CD133 protein with high sensitivity. As well, both these aptamers show superior tumour penetration and retention when compared to the AC133 antibody in a 3D tumour sphere model. These novel CD133 aptamers will aid future development of cancer stem cell targeted therapeutics and molecular imaging. Crown Copyright (C) 2012 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:84 / 95
页数:12
相关论文
共 62 条
[1]   CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles [J].
Beier, Dagmar ;
Hau, Peter ;
Proescholdt, Martin ;
Lohmeier, Annette ;
Wischhusen, Joerg ;
Oefner, Peter J. ;
Aigner, Ludwig ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Beier, Christoph P. .
CANCER RESEARCH, 2007, 67 (09) :4010-4015
[2]   Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment [J].
Bertolini, Giulia ;
Roz, Luca ;
Perego, Paola ;
Tortoreto, Monica ;
Fontanella, Enrico ;
Gatti, Laura ;
Pratesi, Graziella ;
Fabbri, Alessandra ;
Andriani, Francesca ;
Tinelli, Stella ;
Roz, Elena ;
Caserini, Roberto ;
Lo Vullo, Salvatore ;
Camerini, Tiziana ;
Mariani, Luigi ;
Delia, Domenico ;
Calabro, Elisa ;
Pastorino, Ugo ;
Sozzi, Gabriella .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) :16281-16286
[3]   The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells [J].
Bidlingmaier, Scott ;
Zhu, Xiaodong ;
Liu, Bin .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (09) :1025-1032
[4]   Insight into the complex regulation of CD133 in glioma [J].
Campos, Benito ;
Herold-Mende, Christel C. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) :501-510
[5]   Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity [J].
Castriconi, Roberta ;
Dondero, Alessandra ;
Negri, Francesca ;
Bellora, Francesca ;
Nozza, Paolo ;
Carnemolla, Barbara ;
Raso, Alessandro ;
Moretta, Lorenzo ;
Moretta, Alessandro ;
Bottino, Cristina .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (11) :3190-3196
[6]   Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics? [J].
Crea, Francesco ;
Fornaro, Lorenzo ;
Masi, Gianluca ;
Falcone, Alfredo ;
Danesi, Romano ;
Farrar, William .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3487-3488
[7]   Ligand-based targeted therapy for cancer tissue [J].
Das, Manasi ;
Mohanty, Chandana ;
Sahoo, Sanjeeb K. .
EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (03) :285-304
[8]   CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116 [J].
Dittfeld, Claudia ;
Dietrich, Antje ;
Peickert, Susann ;
Hering, Sandra ;
Baumann, Michael ;
Grade, Marian ;
Ried, Thomas ;
Kunz-Schughart, Leoni A. .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) :353-361
[9]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[10]   Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth [J].
Enderling, Heiko ;
Hlatky, Lynn ;
Hahnfeldt, Philip .
THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2012, 9